Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results

Showing results for

The Oxford Vaccine Group is an independent multi-disciplinary clinical trials and epidemiology group based at the Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford. OVG works towards the goal of developing new and improved vaccines for the prevention of infection in adults and children.

Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study.

Firth C. et al, (2026), Hum Vaccin Immunother, 22

Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.

Monk V. et al, (2026), Expert Rev Vaccines, 25

Serological thresholds of risk reduction for infant group B streptococcus disease

Cantrell L. et al, (2026)

In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.

Reiné J. et al, (2026), Comput Biol Chem, 122

Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.

Alsaleh G. et al, (2026), Aging Cell, 25

Levels of bone formation marker P1NP in individuals over 50 years: a systematic review and meta-analysis.

Hesari E. et al, (2026), J Diabetes Metab Disord, 25

Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional study.

Reiné J. et al, (2026), Cell Rep, 45

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data.

Hagedoorn NN. et al, (2026), Vaccine, 85

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.

Hysa A. et al, (2026), PLoS Med, 23

National Cross-Sectional Study Assessing the Positivity Rate and Clinical Manifestations of Human Bocavirus Respiratory Infections Among Hospitalized Children Under 5 Years of Age in Jordan

Abu Lubad M. et al, (2026), Pathogens, 15, 515 - 515

The human immune response to viral vectored vaccine regimens against Ebola virus and Sudan virus in clinical trials

Makinson R., (2026)

The impact of the COVID-19 pandemic on healthy volunteer motivations: a mixed-methods study of participants in plague vaccine trials in the UK and Uganda.

Stuart AS. et al, (2026), BMC Public Health

Willingness to accept paediatric blood sample collection for clinical research purposes in Nepal: a qualitative study.

Dahal A. et al, (2026), BMJ Glob Health, 11

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

Thorn N. et al, (2026), Lancet Infect Dis

Predicting trajectories of illness using RNA velocity of whole blood.

Dunican C. et al, (2026), Nat Commun, 17

Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage at 1-year post-vaccination on rechallenge with Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a controlled human infection study and longitudinal follow-up of a randomised controlled trial.

Chirwa AE. et al, (2026), Lancet Microbe, 7

Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

GBD 2023 Meningitis & Antimicrobial Resistance Collaborators ., (2026), Lancet Neurol, 25, 451 - 468

"Intranasal vaccination with recombinant human adenovirus encoding the trans-sialidase gene protects mice from lethal subcutaneous and oral Trypanosoma cruzi trypomastigote challenges".

Noronha IH. et al, (2026), J Infect Dis

Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.

Jones E. et al, (2026), J Immunol, 215

African-specific genetic loci determine iron status and risk of severe malaria and bacteremia in African children.

Muriuki JM. et al, (2026), Nat Commun

Load More